Structure-Based Discovery of 4-(6-Methoxy-2-methyl-4-(quinolin-4-yl)-9H-pyrimido[4,5-b]indol-7-yl)-3,5-dimethylisoxazole (CD161) as a Potent and Orally Bioavailable BET Bromodomain Inhibitor.
about
Structure-Based Discovery of 4-(6-Methoxy-2-methyl-4-(quinolin-4-yl)-9H-pyrimido[4,5-b]indol-7-yl)-3,5-dimethylisoxazole (CD161) as a Potent and Orally Bioavailable BET Bromodomain Inhibitor.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Structure-Based Discovery of 4 ...... ble BET Bromodomain Inhibitor.
@en
type
label
Structure-Based Discovery of 4 ...... ble BET Bromodomain Inhibitor.
@en
prefLabel
Structure-Based Discovery of 4 ...... ble BET Bromodomain Inhibitor.
@en
P2093
P50
P1476
Structure-Based Discovery of 4 ...... able BET Bromodomain Inhibitor
@en
P2093
Donna McEachern
Jeanne A Stuckey
Jennifer L Meagher
Longchuan Bai
Xiaoqin Li
P304
P356
10.1021/ACS.JMEDCHEM.7B00193
P407
P577
2017-05-02T00:00:00Z